Advertisement
Screener

NEPHROS, INC. (NEPH) Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

NEPHROS, INC. Deferred Revenue

NEPHROS, INC. (NEPH) had Deferred Revenue of $265.00 thousand as of 2017-12-31, per its 10-K filed 2018-02-26.

Discontinued › Balance Sheet › Liabilities

us-gaap:DeferredRevenue · last filed 2018-02-26

  • 2017-12-31: Deferred Revenue $265.00K.
  • 2016-12-31: Deferred Revenue $227.00K; Deferred Revenue as first filed $348.00K.
  • 2016-09-30: Deferred Revenue $365.00K.
  • 2016-06-30: Deferred Revenue $383.00K.
Period endDeferred RevenueDeferred Revenue as first filed
2017-12-31$265.00K
10-K · filed 2018-02-26
2016-12-31$227.00K
10-K · filed 2018-02-26
$348.00K
10-K · filed 2017-03-20
2016-09-30$365.00K
10-Q · filed 2016-11-10
2016-06-30$383.00K
10-Q · filed 2016-08-08
2016-03-31$400.00K
10-Q · filed 2016-05-11
2015-12-31$417.00K
10-K · filed 2017-03-20
2014-12-31$487.00K
10-K · filed 2016-03-30
2014-06-30$873.00K
10-Q · filed 2014-08-14
2013-12-31$703.00K
10-K · filed 2015-04-15
2012-12-31$1.41M
10-K · filed 2014-03-28
2011-12-31$2.09M
10-K · filed 2013-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
DarioHealth Corp. (DRIO)$0.066B-1.39